Ligand Pharmaceuticals (LGND) Convertible Debt (2014 - 2022)
Ligand Pharmaceuticals (LGND) reported Convertible Debt of $176.54 million for Q1 2022, down 49.9% from $352.31 million a year earlier and down 45.0% from the prior quarter.
Powered by 
Analysis
Ligand Pharmaceuticals (LGND) Convertible Debt (2014 - 2022) Analysis & Trends
At the end of FY2021, Ligand Pharmaceuticals posted Convertible Debt of $320.72 million, down 27.5% from FY2020.
- Convertible Debt has a three-year compound annual growth rate of -19.3% (FY2018 to FY2021).
- By year, Convertible Debt came in at $442.29 million in FY2020 (-30.8%), $638.96 million in FY2019 (+4.8%) and $609.86 million in FY2018.
- The Q1 2022 figure ranks as the lowest quarterly Convertible Debt in data going back to Q3 2014.
- Year over year, Convertible Debt has now declined in each of the last nine quarters, with an average decline of 30.6% over the last eight quarters.
- The high point for year-over-year Convertible Debt in five years was Q4 2019 (growth of 4.8%); the low point was Q1 2022 (a decline of 49.9%).
- Per Business Quant data, the three quarters before Q1 2022 came in at $320.72 million (Q4 2021), $316.89 million (Q3 2021) and $315.32 million (Q2 2021).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn |
| 10 | Ligand Pharmaceuticals | 6.18 Bn | 2.65 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2022 | 176.54 Mn |
| Dec 31, 2021 | 320.72 Mn |
| Sep 30, 2021 | 316.89 Mn |
| Jun 30, 2021 | 315.32 Mn |
| Mar 31, 2021 | 352.31 Mn |
| Dec 31, 2020 | 442.29 Mn |
| Sep 30, 2020 | 454.97 Mn |
| Jun 30, 2020 | 449.67 Mn |
| Mar 31, 2020 | 444.43 Mn |
| Dec 31, 2019 | 638.96 Mn |
| Sep 30, 2019 | 631.53 Mn |
| Jun 30, 2019 | 624.21 Mn |
| Mar 31, 2019 | 616.99 Mn |
| Dec 31, 2018 | 609.86 Mn |
| Sep 30, 2018 | 602.84 Mn |
| Jun 30, 2018 | 595.91 Mn |
| Mar 31, 2016 | 204.65 Mn |
| Dec 31, 2015 | 201.99 Mn |
| Sep 30, 2015 | 202.95 Mn |
| Jun 30, 2015 | 200.57 Mn |
API Access
Ligand Pharmaceuticals Convertible Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=convertible-debt&ticker=LGND&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "convertible-debt", "ticker": "LGND", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=convertible-debt&ticker=LGND&period=max&api_key=YOUR_API_KEY");
const data = await res.json();